# Clorox Co: financial statements, quarterly

CLX · NYSE · CIK 21076 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/clx.md) · [Financials](/companies/clx/financials.md) · [Filings](/companies/clx/filings.md) · [Insiders](/companies/clx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,019 d](/filings/0000021076-25-000039.md) | [1,386](/filings/0000021076-24-000040.md) | [1,990](/filings/0000021076-25-000013.md) | [1,814](/filings/0000021076-25-000023.md) | [1,903 d](/filings/0000021076-25-000039.md) | [1,762](/filings/0000021076-25-000053.md) | [1,686](/filings/0000021076-26-000010.md) | [1,668](/filings/0000021076-26-000019.md) | [1,988 d](/filings/0000021076-25-000039.md) | [1,429](/filings/0000021076-25-000053.md) | [1,673](/filings/0000021076-26-000010.md) | [1,670](/filings/0000021076-26-000019.md) |
| Cost of revenue | $m | [1,157 d](/filings/0000021076-25-000039.md) | [854](/filings/0000021076-24-000040.md) | [1,124](/filings/0000021076-25-000013.md) | [1,048](/filings/0000021076-25-000023.md) | [1,019 d](/filings/0000021076-25-000039.md) | [955](/filings/0000021076-25-000053.md) | [948](/filings/0000021076-26-000010.md) | [924](/filings/0000021076-26-000019.md) | [1,064 d](/filings/0000021076-25-000039.md) | [833](/filings/0000021076-25-000053.md) | [951](/filings/0000021076-26-000010.md) | [948](/filings/0000021076-26-000019.md) |
| Gross profit | $m | [862 d](/filings/0000021076-25-000039.md) | [532](/filings/0000021076-24-000040.md) | [866](/filings/0000021076-25-000013.md) | [766](/filings/0000021076-25-000023.md) | [884 d](/filings/0000021076-25-000039.md) | [807](/filings/0000021076-25-000053.md) | [738](/filings/0000021076-26-000010.md) | [744](/filings/0000021076-26-000019.md) | [924 d](/filings/0000021076-25-000039.md) | [596](/filings/0000021076-25-000053.md) | [722](/filings/0000021076-26-000010.md) | [722](/filings/0000021076-26-000019.md) |
| Research and development | $m | [38.0 d](/filings/0000021076-25-000039.md) | [29.0](/filings/0000021076-24-000040.md) | [32.0](/filings/0000021076-25-000013.md) | [32.0](/filings/0000021076-25-000023.md) | [33.0 d](/filings/0000021076-25-000039.md) | [31.0](/filings/0000021076-25-000053.md) | [31.0](/filings/0000021076-26-000010.md) | [27.0](/filings/0000021076-26-000019.md) | [32.0 d](/filings/0000021076-25-000039.md) | [28.0](/filings/0000021076-25-000053.md) | [29.0](/filings/0000021076-26-000010.md) | [27.0](/filings/0000021076-26-000019.md) |
| Selling, general and administrative | $m | [329 d](/filings/0000021076-25-000039.md) | [276](/filings/0000021076-24-000040.md) | [322](/filings/0000021076-25-000013.md) | [301](/filings/0000021076-25-000023.md) | [268 d](/filings/0000021076-25-000039.md) | [281](/filings/0000021076-25-000053.md) | [280](/filings/0000021076-26-000010.md) | [267](/filings/0000021076-26-000019.md) | [296 d](/filings/0000021076-25-000039.md) | [277](/filings/0000021076-25-000053.md) | [262](/filings/0000021076-26-000010.md) | [229](/filings/0000021076-26-000019.md) |
| Interest expense | $m | [21.0 d](/filings/0000021076-25-000039.md) | [21.0](/filings/0000021076-24-000040.md) | [26.0](/filings/0000021076-25-000013.md) | [22.0](/filings/0000021076-25-000023.md) | [21.0 d](/filings/0000021076-25-000039.md) | [21.0](/filings/0000021076-25-000053.md) | [22.0](/filings/0000021076-26-000010.md) | [23.0](/filings/0000021076-26-000019.md) | [22.0 d](/filings/0000021076-25-000039.md) | [23.0](/filings/0000021076-25-000053.md) | [25.0](/filings/0000021076-26-000010.md) | [27.0](/filings/0000021076-26-000019.md) |
| Income tax | $m | [56.0 d](/filings/0000021076-25-000039.md) | [4.0](/filings/0000021076-24-000040.md) | [40.0](/filings/0000021076-25-000013.md) | [8.0](/filings/0000021076-25-000023.md) | [54.0 d](/filings/0000021076-25-000039.md) | [74.0](/filings/0000021076-25-000053.md) | [43.0](/filings/0000021076-26-000010.md) | [63.0](/filings/0000021076-26-000019.md) | [74.0 d](/filings/0000021076-25-000039.md) | [25.0](/filings/0000021076-25-000053.md) | [54.0](/filings/0000021076-26-000010.md) | [65.0](/filings/0000021076-26-000019.md) |
| Net income | $m | [176 d](/filings/0000021076-25-000039.md) | [22.0](/filings/0000021076-24-000040.md) | [93.0](/filings/0000021076-25-000013.md) | [(51.0)](/filings/0000021076-25-000023.md) | [216 d](/filings/0000021076-25-000039.md) | [99.0](/filings/0000021076-25-000053.md) | [193](/filings/0000021076-26-000010.md) | [186](/filings/0000021076-26-000019.md) | [332 d](/filings/0000021076-25-000039.md) | [80.0](/filings/0000021076-25-000053.md) | [157](/filings/0000021076-26-000010.md) | [187](/filings/0000021076-26-000019.md) |
| Diluted EPS | $ per share | not reported | [0.17](/filings/0000021076-24-000040.md) | [0.75](/filings/0000021076-25-000013.md) | [(0.41)](/filings/0000021076-25-000023.md) | not reported | [0.80](/filings/0000021076-25-000053.md) | [1.54](/filings/0000021076-26-000010.md) | [1.50](/filings/0000021076-26-000019.md) | not reported | [0.65](/filings/0000021076-25-000053.md) | [1.29](/filings/0000021076-26-000010.md) | [1.54](/filings/0000021076-26-000019.md) |
| Basic EPS | $ per share | not reported | [0.17](/filings/0000021076-24-000040.md) | [0.75](/filings/0000021076-25-000013.md) | [(0.41)](/filings/0000021076-25-000023.md) | not reported | [0.80](/filings/0000021076-25-000053.md) | [1.55](/filings/0000021076-26-000010.md) | [1.51](/filings/0000021076-26-000019.md) | not reported | [0.65](/filings/0000021076-25-000053.md) | [1.29](/filings/0000021076-26-000010.md) | [1.54](/filings/0000021076-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [367](/filings/0000021076-24-000030.md) | [518](/filings/0000021076-23-000048.md) | [355](/filings/0000021076-24-000010.md) | [219](/filings/0000021076-24-000016.md) | [202](/filings/0000021076-25-000039.md) | [278](/filings/0000021076-24-000040.md) | [290](/filings/0000021076-25-000013.md) | [226](/filings/0000021076-25-000023.md) | [167](/filings/0000021076-26-000019.md) | [166](/filings/0000021076-25-000053.md) | [227](/filings/0000021076-26-000010.md) | [1,187](/filings/0000021076-26-000019.md) |
| Current assets | $m | [1,828](/filings/0000021076-24-000030.md) | [1,911](/filings/0000021076-23-000048.md) | [1,804](/filings/0000021076-24-000010.md) | [1,661](/filings/0000021076-24-000016.md) | [1,622](/filings/0000021076-25-000039.md) | [1,576](/filings/0000021076-24-000040.md) | [1,632](/filings/0000021076-25-000013.md) | [1,590](/filings/0000021076-25-000023.md) | [1,608](/filings/0000021076-26-000019.md) | [1,695](/filings/0000021076-25-000053.md) | [1,728](/filings/0000021076-26-000010.md) | [2,651](/filings/0000021076-26-000019.md) |
| Total assets | $m | [5,945](/filings/0000021076-24-000030.md) | [5,991](/filings/0000021076-23-000048.md) | [5,908](/filings/0000021076-24-000010.md) | [5,805](/filings/0000021076-24-000016.md) | [5,751](/filings/0000021076-25-000039.md) | [5,497](/filings/0000021076-24-000040.md) | [5,577](/filings/0000021076-25-000013.md) | [5,512](/filings/0000021076-25-000023.md) | [5,561](/filings/0000021076-26-000019.md) | [5,528](/filings/0000021076-25-000053.md) | [5,613](/filings/0000021076-26-000010.md) | [6,436](/filings/0000021076-26-000019.md) |
| Current liabilities | $m | [1,917](/filings/0000021076-24-000030.md) | [2,228](/filings/0000021076-23-000048.md) | [2,022](/filings/0000021076-24-000010.md) | [1,846](/filings/0000021076-24-000016.md) | [1,574](/filings/0000021076-25-000039.md) | [1,579](/filings/0000021076-24-000040.md) | [1,730](/filings/0000021076-25-000013.md) | [2,155](/filings/0000021076-25-000023.md) | [1,919](/filings/0000021076-26-000019.md) | [2,234](/filings/0000021076-25-000053.md) | [2,347](/filings/0000021076-26-000010.md) | [3,155](/filings/0000021076-26-000019.md) |
| Total liabilities | $m | [5,557](/filings/0000021076-24-000030.md) | [5,860](/filings/0000021076-23-000048.md) | [5,690](/filings/0000021076-24-000010.md) | [5,550](/filings/0000021076-24-000016.md) | [5,259](/filings/0000021076-25-000039.md) | [5,273](/filings/0000021076-24-000040.md) | [5,456](/filings/0000021076-25-000013.md) | [5,322](/filings/0000021076-25-000023.md) | [5,079](/filings/0000021076-26-000019.md) | [5,390](/filings/0000021076-25-000053.md) | [5,578](/filings/0000021076-26-000010.md) | [6,344](/filings/0000021076-26-000019.md) |
| Long-term debt | $m | [2,477](/filings/0000021076-24-000030.md) | [2,478](/filings/0000021076-23-000048.md) | [2,479](/filings/0000021076-24-000010.md) | [2,480](/filings/0000021076-24-000016.md) | [2,481](/filings/0000021076-25-000039.md) | [2,482](/filings/0000021076-24-000040.md) | [2,483](/filings/0000021076-25-000013.md) | [2,483](/filings/0000021076-25-000023.md) | [2,484](/filings/0000021076-26-000019.md) | [2,485](/filings/0000021076-25-000053.md) | [2,486](/filings/0000021076-26-000010.md) | [2,487](/filings/0000021076-26-000019.md) |
| Current portion of debt | $m | [0.0](/filings/0000021076-24-000030.md) | not reported | not reported | not reported | [0.0](/filings/0000021076-25-000039.md) | not reported | not reported | not reported | [0.0](/filings/0000021076-25-000039.md) | not reported | not reported | not reported |
| Short-term borrowings | $m | [50.0](/filings/0000021076-24-000030.md) | [347](/filings/0000021076-23-000048.md) | [247](/filings/0000021076-24-000010.md) | [111](/filings/0000021076-24-000016.md) | [4.0](/filings/0000021076-25-000039.md) | [4.0](/filings/0000021076-24-000040.md) | [189](/filings/0000021076-25-000013.md) | [54.0](/filings/0000021076-25-000023.md) | [4.0](/filings/0000021076-26-000019.md) | [218](/filings/0000021076-25-000053.md) | [307](/filings/0000021076-26-000010.md) | [1,591](/filings/0000021076-26-000019.md) |
| Shareholders' equity | $m | [220](/filings/0000021076-24-000030.md) | [(37.0)](/filings/0000021076-23-000048.md) | [53.0](/filings/0000021076-24-000010.md) | [91.0](/filings/0000021076-24-000016.md) | [328](/filings/0000021076-25-000039.md) | [60.0](/filings/0000021076-24-000040.md) | [(41.0)](/filings/0000021076-25-000013.md) | [27.0](/filings/0000021076-25-000023.md) | [321](/filings/0000021076-26-000019.md) | [(22.0)](/filings/0000021076-25-000053.md) | [(125)](/filings/0000021076-26-000010.md) | [(67.0)](/filings/0000021076-26-000019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [430 d](/filings/0000021076-25-000039.md) | [20.0](/filings/0000021076-24-000040.md) | [153 d](/filings/0000021076-25-000013.md) | [182 d](/filings/0000021076-25-000023.md) | [340 d](/filings/0000021076-25-000039.md) | [221](/filings/0000021076-25-000053.md) | [180 d](/filings/0000021076-26-000010.md) | [286 d](/filings/0000021076-26-000019.md) | [294 d](/filings/0000021076-25-000039.md) | [93.0](/filings/0000021076-25-000053.md) | [311 d](/filings/0000021076-26-000010.md) | [(122) d](/filings/0000021076-26-000019.md) |
| Capital expenditure | $m | [84.0 d](/filings/0000021076-25-000039.md) | [24.0](/filings/0000021076-24-000040.md) | [52.0 d](/filings/0000021076-25-000013.md) | [55.0 d](/filings/0000021076-25-000023.md) | [81.0 d](/filings/0000021076-25-000039.md) | [39.0](/filings/0000021076-25-000053.md) | [53.0 d](/filings/0000021076-26-000010.md) | [53.0 d](/filings/0000021076-26-000019.md) | [75.0 d](/filings/0000021076-25-000039.md) | [36.0](/filings/0000021076-25-000053.md) | [42.0 d](/filings/0000021076-26-000010.md) | [43.0 d](/filings/0000021076-26-000019.md) |
| Dividends paid | $m | [146 d](/filings/0000021076-25-000039.md) | [149](/filings/0000021076-24-000040.md) | [149 d](/filings/0000021076-25-000013.md) | [148 d](/filings/0000021076-25-000023.md) | [149 d](/filings/0000021076-25-000039.md) | [151](/filings/0000021076-25-000053.md) | [151 d](/filings/0000021076-26-000010.md) | [150 d](/filings/0000021076-26-000019.md) | [150 d](/filings/0000021076-25-000039.md) | [151](/filings/0000021076-25-000053.md) | [151 d](/filings/0000021076-26-000010.md) | [150 d](/filings/0000021076-26-000019.md) |
| Share repurchases | $m | [0.0 d](/filings/0000021076-25-000039.md) | [0.0](/filings/0000021076-24-000040.md) | [0.0 d](/filings/0000021076-25-000013.md) | [0.0 d](/filings/0000021076-25-000023.md) | [0.0 d](/filings/0000021076-25-000039.md) | [107](/filings/0000021076-25-000053.md) | [150 d](/filings/0000021076-26-000010.md) | [0.0 d](/filings/0000021076-26-000019.md) | [75.0 d](/filings/0000021076-25-000039.md) | [129](/filings/0000021076-25-000053.md) | [127 d](/filings/0000021076-26-000010.md) | [0.0 d](/filings/0000021076-26-000019.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [124](/filings/0000021076-23-000048.md) | [124](/filings/0000021076-24-000010.md) | [124](/filings/0000021076-24-000016.md) | [125](/filings/0000021076-24-000040.md) | [125](/filings/0000021076-25-000013.md) | [124](/filings/0000021076-25-000023.md) | [125](/filings/0000021076-25-000053.md) | [125](/filings/0000021076-26-000010.md) | [124](/filings/0000021076-26-000019.md) | [123](/filings/0000021076-25-000053.md) | [122](/filings/0000021076-26-000010.md) | [122](/filings/0000021076-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 120,921,351 at 2026-04-16, from the cover of the [10-Q filed 2026-04-30](/filings/0000021076-26-000019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.